Clinical Study

A Study To Evaluate An Oral Investigational Drug To See If It Helps Treat Symptoms In Adults With Adhd.

Posted Date: Jan 27, 2020

  • Investigator: Caleb Adler
  • Specialties: ADD/ADHD, Psychiatry/Psychology
  • Type of Study: Drug

A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults with Attention-deficit/Hyperactivity Disorder (Trial 405-201-00014)

Criteria:

18 To 55 Years Of Age, Diagnosis Of Adhd

Keywords:

Adult, Add, Adhd

For More Information:

Emily Rummelhoff
513-558-4295
emily.rummelhoff@uc.edu